COSCIENS Biopharma Inc. (CSCIF)

Market Cap	6.21M -35.1%
Revenue (ttm)	8.00M -10.3%
Net Income	4.05M
EPS	1.28
Shares Out	n/a
PE Ratio	1.53
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,373
Open	2.100
Previous Close	2.100
Day's Range	1.796 - 2.100
52-Week Range	0.791 - 4.400
Beta	1.88
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 12, 2026

About COSCIENS Biopharma

COSCIENS Biopharma Inc., a life science company, develops and commercializes products for the cosmeceutical, nutraceutical and pharmaceutical markets in the United States, Germany, the United Kingdom, and internationally. It operates through Active Ingredient and Pharmaceutical segments. The company offers active ingredients comprising oat beta glucan, a functional ingredient that supports overall health and wellness; oat powder and peptides; oat oil which is extracted from whole oat kernels by a gentle process that retains all the important bi...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1990
• Employees: 28
• Stock Exchange: OTCMKTS
• Ticker Symbol: CSCIF

Financial Performance

In 2025, COSCIENS Biopharma's revenue was $7.50 million, a decrease of -21.79% compared to the previous year's $9.59 million. Losses were -$10.36 million, -32.34% less than in 2024.